DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
8••••• I••
Healthcare & Pharmaceuticalsgroup grade Boff every schedule since Mar 31, 2024sponsor unattributed
Also written as: Akoya; Analogic; Cato Research; Cerus; Compass Health; Emmes Corporation; EmpiRx; Forge Biologics
Nothing material in the last 200 days. No dated change on record yet.
Mark path, consensus per quarter end
99¢ · 98¢ · 98¢ · 98¢Q2 2023 to Q1 2024
Principal held
at least $3.0M
sum of BDC pieces, a lower bound
Fair value
$2.9M
98c on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
1
0 equity pieces beside them
Next maturity
Jul 2, 2026
no dated debt inside 24 months
On the tape since
Mar 31, 2022
latest Mar 31, 2024
Events
2
dated, non-routine
Lender marks
each lender's own fair value over cost at Mar 31, 2024, folded to one row per lender
| Lender | Exposure | Current mark | QoQ change |
|---|---|---|---|
| M••••• F•••••••• I••••••••• C••• | $3M | 98¢ | 0 pts |
Every BDC piece · 1 position across 1 lenderlargest principal first, with instrument and rate
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| M••••• F•••••••• I••••••••• C••• | term loan first lien F•••• L••• S•••••• D••• S•••+586, 1.50% F•••• M••••••• D••• 07/02/26 | $3.0M | $2.9M 98c | S+586 bp |
Capital structure as the BDCs see it
latest quarter end Mar 31, 2024
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien exited Mar 31, 2024 | at least $3.0M | 98c | S+586 bp | Jul 2, 2026 | 1 |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Mar 31, 2024 | 1 | $3.0M | $2.9M | 98c | 0 |
| Dec 31, 2023 | 1 | $3.1M | $3.1M | 98c | 0 |
| Sep 30, 2023 | 1 | $3.2M | $3.2M | 98c | 0 |
| Jun 30, 2023 | 1 | $3.3M | $3.3M | 99c | 0 |
All 6 quartersShow fewer
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Mar 31, 2023 | 1 | $3.4M | $3.4M | n/a | 0 |
| Dec 31, 2022 | 1 | $7.3M | $7.2M | 197c | 0 |
What changed
- Facility left every BDC scheduleMar 31, 2024
- New borrower on a BDC scheduleMar 31, 2022
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- 83BARderivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 1 BDCderived
- Industry
- Healthcare & Pharmaceuticalsreportedas one filer wrote it